Clinicopathologic features and prognosis of epithelioid glioblastoma.

CONCLUSION: E-GBM is a highly invasive and rare malignant nervous system tumor, with poor prognosis and lack of clinical specificity. Immunohistochemically, the higher expression of CK, GFAP and Ki67 proliferation index is more conducive to the diagnosis and differential diagnosis of E-GBM. Smoking, brain MR showing tumor invasion of cortex, TERT mutation, radiotherapy, and chemotherapy are independent risk factors affecting the prognosis (survival time) of patients.
PMID: 32782671 [PubMed]

Source: International Journal of Clinical and Experimental Pathology - August 13, 2020 Category: Pathology Authors: Wang S, He Q, Zhang Q, Guan B, Zhou X Tags: Int J Clin Exp Pathol Source Type: research